FVR Stock Analysis: FrontView REIT | NYSE
REIT - Diversified | NYSE, USA | Market Cap: 490m USD | 12M Return: 89.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.02M
Qual. Beats: 0
Rev. Trend: 98.4%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 1.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
FrontView REIT, Inc. (NYSE: FVR) is an internally managed net-lease real estate investment trust that acquires, owns, and operates properties with road frontage located in high-traffic retail corridors. The company targets highly visible sites with strong real estate fundamentals and adaptable building formats that can accommodate a range of tenants over time.
As of March 31, 2026, FrontViews portfolio consisted of 309 directly owned frontage properties across 36 U.S. states, leased to a diversified tenant base spanning 16 industries, including medical and dental, quick-service and casual dining, financial services, cellular retail, automotive-related, fitness, and general retail. The tenant mix is weighted toward service and necessity-based businesses, which typically generate relatively stable, recurring demand.
Net-lease REITs like FrontView generally structure leases so that tenants are responsible for most property operating expenses, including taxes, insurance, and maintenance, providing the landlord with predictable, largely passive rental income. As a small-cap retail REIT listed on the NYSE following its October 2024 IPO and headquartered in Dallas, FrontViews investment approach combines the long-duration income characteristics typical of net-lease operators with a focus on the visibility and foot-traffic attributes of frontage real estate.
- Net interest expense rises as Fed holds rates higher
- Acquisition pace drives external portfolio growth across U.S. markets
- Same-store rent escalations boost contractual revenue
- Tenant credit concerns rise amid retail sector pressures
| Net Income: -2.52m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.28 > 0.02 and ΔFCF/TA -22.71 > 1.0 |
| NWC/Revenue: 13.38% < 20% (prev 16.33%; Δ -2.95% < -1%) |
| CFO/TA 0.05 > 3% & CFO 41.1m > Net Income -2.52m |
| Net Debt (332.0m) to EBITDA (51.4m): 6.46 < 3 |
| Current Ratio: 1.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (22.3m) vs 12m ago 28.85% < -2% |
| Gross Margin: -32.14% > 18% (prev 81.31%; Δ -113.5% > 0.5%) |
| Asset Turnover: 7.98% > 50% (prev 7.04%; Δ 0.95% > 0%) |
| Interest Coverage Ratio: 0.80 > 6 (EBIT TTM 14.2m / Interest Expense TTM 17.7m) |
| A: 0.01 (Total Current Assets 21.9m - Total Current Liabilities 12.7m) / Total Assets 869.8m |
| B: -0.04 (Retained Earnings -32.9m / Total Assets 869.8m) |
| C: 0.02 (EBIT TTM 14.2m / Avg Total Assets 865.3m) |
| D: 1.18 (Book Value of Equity 418.1m / Total Liabilities 355.6m) |
| Altman-Z'' = 1.29 = BB |
| DSRI: 0.93 (Receivables 12.3m/11.6m, Revenue 69.1m/60.6m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 1.22 (AQ_t 0.17 / AQ_t-1 0.14) |
| SGI: 1.14 (Revenue 69.1m / 60.6m) |
| TATA: -0.05 (NI -2.52m - CFO 41.1m) / TA 869.8m) |
| Beneish M = -2.86 (Cap -4..+1) = A |
As of July 17, 2026, the stock is trading at USD 21.83 with a total of 181,753 shares traded. Over the past week, the price has changed by +4.10%, over one month by +13.73%, over three months by +30.32% and over the past year by +89.21%.
Current recommended Stop Loss: 20.80 (which is 4.7% or 1.5 ATR below the current price).
FrontView REIT has received a consensus analysts rating of 4.20. Therefore, it is recommended to buy FVR.
- StrongBuy: 2
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 20.8 | -4.9% |
P/S = 7.1501
P/B = 1.153
Revenue TTM = 69.1m USD
EBIT TTM = 14.2m USD
EBITDA TTM = 51.4m USD
Long Term Debt = 312.9m USD (from longTermDebt, last quarter)
Short Term Debt = 12.7m USD (from shortTermDebt, last quarter)
Debt = 341.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 14.2m
Net Debt = 332.0m USD (calculated: Debt 341.3m - CCE 9.29m)
Enterprise Value = 821.7m USD (489.8m + Debt 341.3m - CCE 9.29m)
Interest Coverage Ratio = 0.80 (Ebit TTM 14.2m / Interest Expense TTM 17.7m)
EV/FCF = -3.36x (Enterprise Value 821.7m / FCF TTM -244.3m)
FCF Yield = -29.73% (FCF TTM -244.3m / Enterprise Value 821.7m)
FCF Margin = -353.7% (FCF TTM -244.3m / Revenue TTM 69.1m)
Net Margin = -3.64% (Net Income TTM -2.52m / Revenue TTM 69.1m)
Gross Margin = -32.14% ((Revenue TTM 69.1m - Cost of Revenue TTM 91.3m) / Revenue TTM)
Gross Margin QoQ = 2.81% (prev none%)
Tobins Q-Ratio = 0.94 (Enterprise Value 821.7m / Total Assets 869.8m)
Interest Expense / Debt = 5.20% (Interest Expense 17.7m / Debt 341.3m)
Taxrate = 14.89% (70.0k / 470k)
NOPAT = 12.1m (EBIT 14.2m * (1 - 14.89%))
Current Ratio = 0.53 (Total Current Assets 21.9m / Total Current Liabilities 41.2m)
Debt / Equity = 0.82 (Debt 341.3m / totalStockholderEquity, last quarter 418.1m)
Debt / EBITDA = 6.46 (Net Debt 332.0m / EBITDA 51.4m)
Debt / FCF = -1.36 (negative FCF - burning cash) (Net Debt 332.0m / FCF TTM -244.3m)
Total Stockholder Equity = 391.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.29% (Net Income -2.52m / Total Assets 869.8m)
RoE = -0.64% (Net Income TTM -2.52m / Total Stockholder Equity 391.1m)
RoCE = 2.02% (EBIT 14.2m / Capital Employed (Equity 391.1m + L.T.Debt 312.9m))
RoIC = 1.40% (NOPAT 12.1m / Invested Capital 866.3m)
WACC = 6.07% (E(489.8m)/V(831.0m) * Re(7.22%) + D(341.3m)/V(831.0m) * Rd(5.20%) * (1-Tc(0.15)))
Discount Rate = 7.22% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 81.53 | Cagr: 19.30%
[DCF] Fair Price = unknown (Cash Flow -244.3m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.20 | # QB: 0
Revenue Correlation: 98.42 | Revenue CAGR: 17.92% | SUE: 1.29 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=+25% | Analysts=5
EPS next Quarter (2026-09-30): EPS=-0.01 | Chg30d=N/A | Revisions=+25% | Analysts=4
EPS current Year (2026-12-31): EPS=-0.01 | Chg30d=N/A | Revisions=-25% | GrowthEPS=+96.4% | GrowthRev=+11.3%
EPS next Year (2027-12-31): EPS=0.01 | Chg30d=+119.79% | Revisions=+17% | GrowthEPS=+262.5% | GrowthRev=+10.9%
[Analyst] Revisions Ratio: +22% (up=4, down=2)